Search research articles
Contact Us
Filters
Showing results (11-20 of 70) with videos related to
Page
of 7
Sort By:
Cardiovascular Drugs and Therapy
|
September 28, 2024
Correction to: Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
Natalie Arnold, Wolfgang Koenig
Current Opinion in Cardiology
|
September 3, 2021
Persistent inflammatory residual risk despite aggressive cholesterol-lowering therapy: what is next?
Natalie Arnold, Wolfgang Koenig
Journal of Vitreoretinal Diseases
|
April 28, 2025
Cancer-Associated Retinopathy Presenting as Panuveitis Secondary to Minimally Invasive Follicular Thyroid Carcinoma
Natalie Arnold, Amit Mishra, Mark Seamone
Current Opinion in Lipidology
|
January 26, 2024
C-reactive protein, pharmacological treatments and diet: how to target your inflammatory burden
Benjamin Bay, Natalie Arnold, Christoph Waldeyer
Herz
|
April 25, 2022
[Cost-benefit analysis of new lipid-lowering agents]
Christopher Blaum, Natalie Arnold, Christoph Waldeyer
Deutsches Arzteblatt International
|
June 16, 2026
In Reply
Natalie Arnold, Cristian Riccio, Stefan Blankenberg, et al.
Public Health Reports (Washington, D.C. : 1974)
|
March 11, 2011
Aligning a departmental D(R)PH program with the new ASPH competencies
Jeanette M Trauth, Patricia I Documét, Mary Hawk, et al.
European Cardiology
|
June 7, 2021
Inflammation and Cardiovascular Disease: The Future
Natalie Arnold, Katharina Lechner, Christoph Waldeyer, et al.
Die Naturwissenschaften
|
December 12, 2019
Acacia trees with parasitic ants have fewer and less spacious spines than trees with mutualistic ants
Sabrina Amador-Vargas, Jared Dyer, Natalie Arnold, et al.
Journal of the American College of Cardiology
|
September 29, 2025
Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology
George A Mensah, Natalie Arnold, Sumanth D Prabhu, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 70) with videos related to
Sort By:
Page
of 7
Cardiovascular Drugs and Therapy
|
September 28, 2024
Correction to: Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
Natalie Arnold, Wolfgang Koenig
Current Opinion in Cardiology
|
September 3, 2021
Persistent inflammatory residual risk despite aggressive cholesterol-lowering therapy: what is next?
Natalie Arnold, Wolfgang Koenig
Journal of Vitreoretinal Diseases
|
April 28, 2025
Cancer-Associated Retinopathy Presenting as Panuveitis Secondary to Minimally Invasive Follicular Thyroid Carcinoma
Natalie Arnold, Amit Mishra, Mark Seamone
Current Opinion in Lipidology
|
January 26, 2024
C-reactive protein, pharmacological treatments and diet: how to target your inflammatory burden
Benjamin Bay, Natalie Arnold, Christoph Waldeyer
Herz
|
April 25, 2022
[Cost-benefit analysis of new lipid-lowering agents]
Christopher Blaum, Natalie Arnold, Christoph Waldeyer
Deutsches Arzteblatt International
|
June 16, 2026
In Reply
Natalie Arnold, Cristian Riccio, Stefan Blankenberg, et al.
Public Health Reports (Washington, D.C. : 1974)
|
March 11, 2011
Aligning a departmental D(R)PH program with the new ASPH competencies
Jeanette M Trauth, Patricia I Documét, Mary Hawk, et al.
European Cardiology
|
June 7, 2021
Inflammation and Cardiovascular Disease: The Future
Natalie Arnold, Katharina Lechner, Christoph Waldeyer, et al.
Die Naturwissenschaften
|
December 12, 2019
Acacia trees with parasitic ants have fewer and less spacious spines than trees with mutualistic ants
Sabrina Amador-Vargas, Jared Dyer, Natalie Arnold, et al.
Journal of the American College of Cardiology
|
September 29, 2025
Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology
George A Mensah, Natalie Arnold, Sumanth D Prabhu, et al.
Page
of 7